Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia.

Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders, causing impaired secretion of cortisol and aldosterone from the adrenal cortex, with subsequent overproduction of adrenal androgens. The most common enzyme defect causing CAH is steroid 21-hydroxylase deficiency. To determine the mutational spectrum in the Hungarian CAH population, the CYP21 active gene was analyzed using PCR. A total of 297 Hungarian patients with 21-hydroxylase deficiency are registered in the 2nd Department of Pediatrics, Budapest, Hungary, and their clinical status was evaluated. Blood samples for CYP21 genotype determination could be obtained from 167 patients (representing 306 unrelated chromosomes and 56.2% of the total group of patients). Eight of the most common mutations were screened [In2 (intron 2 splice mutation), I172N, Del (Del: apparents large gene conversion), Q318X, R356W, 1761Tins, ClusterE6, V281L] using allele-specific amplification. The most frequent mutation in the Hungarian CAH population was found to be In2. Our results have shown a good genotype/phenotype correlation in case of most mutations; the In2 mutation is associated mostly with the severe form of the disease, whereas I172N was expressed in a wide spectrum of phenotypes. 1999)

[1]  S. Berenbaum,et al.  Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia , 1998, Pediatrics.

[2]  J. Partanen,et al.  Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. , 1997, The Journal of clinical endocrinology and metabolism.

[3]  M. New,et al.  21‐Hydroxylase Deficiency , 1997, Annals of the New York Academy of Sciences.

[4]  J. Seckl,et al.  How safe is long-term prenatal glucocorticoid treatment? , 1997, JAMA.

[5]  Miller Wl Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1997 .

[6]  I. Bergadá,et al.  Mutations of the Steroid 21-Hydroxylase Gene in an Argentinian Population of 36 Patients with Classical Congenital Adrenal Hyperplasia , 1997, Journal of pediatric endocrinology & metabolism : JPEM.

[7]  G. Chiumello,et al.  Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency , 1996, Human Genetics.

[8]  G. Rumsby,et al.  Non-expression of a common mutation in the 21-hydroxylase gene: implications for prenatal diagnosis and carrier testing. , 1996, Journal of medical genetics.

[9]  M. New,et al.  Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. , 1995, The Journal of clinical endocrinology and metabolism.

[10]  M. New,et al.  Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia). , 1995, The American journal of medicine.

[11]  M. New,et al.  Prenatal Diagnosis and Treatment of Congenital Adrenal Hyperplasia , 1994, The Journal of pediatric endocrinology.

[12]  H. Luthman,et al.  MUTATIONAL SPECTRUM OF THE STEROID 21-HYDROXYLASE GENE , 1993, Pediatric Research.

[13]  M. Tusié-Luna,et al.  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1992, The Journal of clinical investigation.

[14]  P. White,et al.  Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. , 1991, American journal of human genetics.

[15]  M. C. Hu,et al.  A missense mutation at Ile172----Asn or Arg356----Trp causes steroid 21-hydroxylase deficiency. , 1990, The Journal of biological chemistry.

[16]  M. Draznin,et al.  Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification. , 1990, Molecular endocrinology.

[17]  K. Fujieda,et al.  Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1988, Pediatrics.

[18]  P. White,et al.  Congenital adrenal hyperplasia. (First of two parts) , 1987 .

[19]  L. Madisen,et al.  DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. , 1987, American journal of medical genetics.

[20]  I. Dunham,et al.  Molecular characterization of the HLA‐linked steroid 21‐hydroxylase B gene from an individual with congenital adrenal hyperplasia. , 1987, The EMBO journal.

[21]  P. White,et al.  Structure of human steroid 21-hydroxylase genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  O. Gotoh,et al.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. New,et al.  Congenital adrenal hyperplasia. , 1988, Biochemical Society transactions.